Test Price
2,800 AED✅ Home Collection Available
GFER Gene-Related Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GFER للاعتلال العضلي الميتوكوندري التقدمي مع الساد الخلقي وفقدان السمع وتأخر النمو – اختبار التسلسل الجيني الكامل في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary — Diagnostic Confidence
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy, available 8 AM – 11 PM daily.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for comprehensive result interpretation by certified genetic counselors.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي — الثقة التشخيصية
اختبار جيني تشخيصي فائق الدقة لتحديد الطفرات المُمْرِضة في جين GFER المرتبطة بالاعتلال العضلي الميتوكوندري التقدمي مع الساد الخلقي وفقدان السمع وتأخر النمو، يُجرى وفقاً لأعلى معايير الجودة العالمية ISO 9001:2015 وتحت إشراف هيئة الصحة بدبي. يشمل خدمة سحب الدم المنزلية المعتمدة بسلسلة تبريد موثقة واستشارة وراثية متكاملة بعد صدور النتائج.
Overview
The GFER Gene Genetic Test is a comprehensive next-generation sequencing assay that analyzes the entire coding region of the GFER (Growth Factor, Augmenter of Liver Regeneration) gene to detect pathogenic variants causing mitochondrial progressive myopathy with congenital cataract, sensorineural hearing loss, and global developmental delay. This test provides definitive molecular confirmation for clinical diagnosis, guides targeted management, and enables informed family planning through accurate recurrence risk assessment.
اختبار تسلسل جيني كامل لجين GFER باستخدام تقنية الجيل التالي (NGS) لكشف الطفرات المسببة للاعتلال العضلي الميتوكوندري التقدمي المصحوب بالساد الخلقي وفقدان السمع الحسي العصبي وتأخر النمو الشامل، مما يتيح تشخيصاً جزيئياً دقيقاً وإرشاداً وراثياً متكاملاً للعائلات المتضررة.
| Feature | Our GFER NGS Test | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | Full gene coverage with >99.9% analytical sensitivity; detects SNVs, indels, and copy number variants | Sequential exon-by-exon analysis; may miss deep intronic variants and large deletions |
| Methodology | NGS (Next-Generation Sequencing) with confirmatory Sanger validation | Sanger Sequencing only; limited throughput |
| Turnaround Speed | 3 to 4 Weeks with comprehensive clinical report | 6 to 8 Weeks for full gene coverage |
Physician Insight & Safety Protocol
Clinical Note from Dr. Prabhakar Reddy (DHA License: 61713011):
"The GFER gene encodes a critical mitochondrial disulfide relay protein, and pathogenic variants produce a distinct syndromic phenotype that requires careful clinical correlation. I emphasize that this genetic test result must always be interpreted within the full clinical context—alongside neurological examination, audiological assessment, ophthalmological evaluation, and detailed developmental history—to ensure accurate diagnosis. Families should understand that a positive result confirms the molecular etiology and empowers targeted surveillance, while a negative or variant-of-uncertain-significance result may necessitate broader genomic investigation or periodic reanalysis."
⚠ MEDICATION NOTICE: Do not discontinue any prescribed medication or supplement without consulting your treating physician. Genetic testing does not replace ongoing clinical management. Altering medication regimens without medical supervision may lead to serious adverse events including metabolic decompensation or seizure exacerbation in mitochondrial disorders.
Patient Safety: Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Home Collection:
- Active febrile illness (temperature ≥38.5°C) within 24 hours of scheduled collection
- Known bleeding diathesis or platelet count below 50,000/µL without prior physician clearance
- Acute metabolic crisis or hospital admission within the preceding 48 hours
- Inability to provide valid informed consent (patient or legal guardian for minors per UAE CDS Law 2026)
- Recent blood transfusion (within 14 days) that may confound germline DNA analysis
Emergency Red Flags — Seek Immediate Medical Attention:
- Sudden worsening of muscle weakness affecting respiratory function
- New-onset seizures or status epilepticus
- Acute visual loss or rapid cataract progression with ocular pain
- Signs of acute liver dysfunction (jaundice, encephalopathy, coagulopathy)
- Severe metabolic acidosis or hypoglycemia unresponsive to oral intake
This test is performed under Facility License No. 9834453. In case of medical emergency, dial 998 (UAE Ambulance) or 999 (UAE Police) immediately.
Patient FAQ & Clinical Guidance
1. What is the GFER gene test, and why is it essential for diagnosing mitochondrial progressive myopathy with congenital cataract and hearing loss?
The GFER gene NGS test comprehensively sequences the entire GFER coding region to identify pathogenic mutations responsible for this rare autosomal recessive mitochondrial disorder, enabling definitive molecular diagnosis, precise recurrence risk counseling, and informed clinical management planning for affected individuals and their families.
ما هو اختبار جين GFER ولماذا يُعد ضرورياً لتشخيص الاعتلال العضلي الميتوكوندري التقدمي مع الساد الخلقي وفقدان السمع؟
اختبار تسلسل كامل لجين GFER باستخدام تقنية الجيل التالي يكشف الطفرات المسببة لهذا الاضطراب الجسدي المتنحي النادر، مما يوفر تشخيصاً جزيئياً قاطعاً وإرشاداً وراثياً دقيقاً للعائلات المتضررة حول احتمالات تكرار المرض وخيارات الإدارة السريرية.
2. How is the sample collected for this genetic test, and what turnaround time should I expect?
A certified DHA-licensed phlebotomist performs a simple venous blood draw or FTA card finger-prick during a scheduled home visit, with specimens transported under ISO-certified cold-chain conditions to our accredited laboratory; you will receive your comprehensive clinical report within 3 to 4 weeks.
كيف تُجمع العينة لهذا الاختبار الجيني وما هي المدة المتوقعة لصدور النتائج؟
يقوم أخصائي سحب دم مرخص من هيئة الصحة بدبي بسحب عينة دم وريدية بسيطة أو وخز إصبع على بطاقة FTA خلال زيارة منزلية مجدولة، وتُنقل العينات تحت ظروف سلسلة تبريد معتمدة دولياً إلى مختبرنا المرخص، وتصدر النتائج السريرية الشاملة خلال 3 إلى 4 أسابيع.
3. Is the GFER gene NGS test covered by medical insurance in the UAE, and how do I verify my coverage?
Many UAE-based insurance providers cover medically necessary genetic testing when supported by a specialist referral from a neurologist or pediatrician; our dedicated billing team offers direct insurance verification via WhatsApp at +971 54 548 8731, confirming your policy benefits before sample collection.
هل يغطي التأمين الطبي في الإمارات اختبار جين GFER وكيف يمكنني التحقق من تغطيتي التأمينية؟
تغطي معظم شركات التأمين في دولة الإمارات الفحوصات الجينية الضرورية طبياً عند تقديم تحويل من طبيب مختص في الأعصاب أو طب الأطفال، ويوفر فريقنا المتخصص خدمة التحقق المباشر من التغطية التأمينية عبر تطبيق واتساب على الرقم 971545488731 قبل إجراء سحب العينة.
Pre-Test Requirements & Clinical Documentation
- Clinical History: Comprehensive neurological, ophthalmological, and audiological history of the patient must be provided, including age of symptom onset, developmental milestones, and any prior metabolic or mitochondrial workup.
- Genetic Counseling: A mandatory pre- genetic counseling session is required to construct a detailed pedigree chart documenting all family members affected by GFER-related myopathy, congenital cataract, hearing loss, or developmental delay, in compliance with UAE Federal Decree-Law No. 41 of 2024 (Art. 87).
- Accepted Sample Types: Whole Blood (EDTA tube), Extracted DNA (minimum 1 µg at ≥50 ng/µL), or One Drop of Blood on FTA Card. All samples must be collected and transported per ISO 9001:2015 cold-chain protocols.
- Consent: Written informed consent is mandatory. For minors, consent must be provided by a legal guardian in accordance with UAE CDS Law 2026 and UAE Personal Data Protection Law (PDPL).
UAE Regulatory Compliance & Accreditation
- ✓ Federal Decree-Law No. 41 of 2024 (Article 87) — Genetic Testing & Counseling Compliance
- ✓ UAE CDS Law 2026 — Minor Protection & Guardian Consent Mandates
- ✓ UAE PDPL — Personal Data Privacy & Genomic Data Protection
- ✓ ISO 9001:2015 Certified — Cert: INT/EGQ/2509DA/3139
- ✓ DHA-MOHAP Standard Nomenclature Compliance
- ✓ Facility License: 9834453 — DHA Regulated
2026 ICD-10-CM Codes: G71.8 (Other Primary Disorders of Muscles — Mitochondrial Myopathy), H90.5 (Unspecified Sensorineural Hearing Loss — Congenital), Q12.0 (Congenital Cataract), Z15.89 (Genetic Susceptibility to Other Disease).
LOINC Code: 86204-6 — Genetic Disease Sequence Variation Panel (NGS).
Methodology: Next-Generation Sequencing (NGS) with confirmatory Sanger sequencing validation and bioinformatic analysis per 2026 AI Medical Dataset standards; variant classification per ACMG/AMP guidelines.
Primary Referring Specialists: Neurologist, Pediatrician, Neonatologist.
Price: 2800 AED | TAT: 3 to 4 Weeks | Support: WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians